2C23.2

ICD-11 MMS 2026-01

Malignant neoplasms of supraglottis of larynx

Coding note from above levels

For use of this category, reference should be made to the mortality coding rules and guidelines in the Reference Guide.

Excludes

  • 2B6A – Malignant neoplasm of anterior surface of epiglottis

Exclusions from above levels

  • http://id.who.int/icd/entity/1965082709 – Malignant mesenchymal neoplasms
  • 2C51.2 – Mesotheliomas of peritoneum
  • http://id.who.int/icd/entity/879154182 – Neoplasms of central nervous system or related structures
Show allHide
  • http://id.who.int/icd/entity/944754984 – Neoplasms of haematopoietic or lymphoid tissues

Child codes

  • 2C23.20 – Squamous cell carcinoma of larynx, supraglottis
  • 2C23.2Y – Other specified malignant neoplasms of larynx, supraglottis
  • 2C23.2Z – Malignant neoplasms of supraglottis of larynx, unspecified

Sibling codes

  • 2C23.1 – Malignant neoplasms of glottis of larynx
  • 2C23.3 – Malignant neoplasms of subglottis of larynx
  • 2C23.4 – Malignant neoplasm of laryngeal cartilage
  • 2C23.5 – Malignant neoplasm of overlapping lesion of larynx
  • 2C23.Z – Malignant neoplasms of larynx, unspecified

Foundation entity

Malignant neoplasms of supraglottis of larynx – http://id.who.int/icd/entity/946898373

Allowed postcoordination axes

Part of: 2C23: Malignant neoplasms of larynx › 02: Neoplasms